← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2009Last known activity
Nov 30, 2024
Timeline
1930s
- Jun 1, 1939
Laboratorio Elea S.A.C.I.F. y A.— Founded
Drugs by trial phase (16 distinct, 22 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Adenocarcinoma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Colorectal Neoplasms
- Condylomata Acuminata
- Gastrointestinal Hemorrhage
- Hemorrhage
- HIV Infections
- Immunologic Deficiency Syndromes
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Macular Degeneration
- Neuroblastoma
- Retinoblastoma
- Sarcoma, Ewing
- Virus Diseases
- Wilms Tumor
Recent trials (22)
- NCT06629389Lead sponsorPhase 2Nov 30, 2024
- NCT05668650Lead sponsorPhase 3Mar 31, 2023
- NCT04897516Lead sponsorPhase 3Jul 28, 2021
- NCT04560881Lead sponsorPhase 3Sep 16, 2020
- NCT04355936Lead sponsorPhase 2May 15, 2020
- NCT04381884Lead sponsorPhase 2May 11, 2020
- NCT03317236Lead sponsorPhase 4Mar 13, 2017
- NCT03668054Lead sponsorPhase 3Feb 7, 2017
- NCT02998983Lead sponsorPhase 2Nov 1, 2016
- NCT03309566Lead sponsorPhase 4Sep 4, 2016
- NCT02069704CollaboratorPhase 1Oct 1, 2014
- NCT02583464Lead sponsorPhase 1Sep 1, 2014
- NCT02268045CollaboratorPhase 3May 1, 2013
- NCT01623206Lead sponsorPhase 2Apr 1, 2013
- NCT01606072Lead sponsorPhase 2Nov 1, 2011
Details
- Founded
- Buenos Aires, AR Jun 1, 1939
- Last known activity
- Nov 30, 2024